Airway remodeling (AR) is a progressive pathological feature of the obstructive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD). The pathology manifests itself in the form of significant, progressive, and (to date) seemingly irreversible changes to distinct respiratory structural compartments. Consequently, AR correlates with disease severity and the gradual decline in pulmonary function associated with asthma and COPD. Although current asthma/COPD drugs manage airway contraction and inflammation, none of these effectively prevent or reverse features of AR. In this review, we provide a brief overview of the features and putative mechanisms affecting AR. We further discuss recently proposed strategies with promise for deterring or treating AR.
Recommended CitationNayak, Ajay P.; Deshpande, Deepak A.; and Penn, Raymond B., "New targets for resolution of airway remodeling in obstructive lung diseases." (2018). Center for Translational Medicine Faculty Papers. Paper 48.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.